Tuesday, June 21, 2016
- 12:30pm-2:00pm
-
Duodopa for the treatment of severe restless legs syndrome
Restless legs syndrome and other sleep disorders · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Dynamic and static posturographic analysis among fallers and non- faller Parkinson’s disease (PD) patients using Neurocom SMART EquiTest
Parkinson's disease: Pathophysiology · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Dysregulated macroautophagy and mitochondrial dynamics in PD with glucocerebrosidase mutations
- 12:30pm-2:00pm
-
E326K GBA polymorphism and Parkinson’s disease in Russian population
Parkinson's disease: Genetics · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Effect of European physiotherapy guideline for Parkinson´s disease and Microsoft Kinect® adventures games training on postural control, cognition and quality of life: Randomized clinical trial
Technology · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Effect of genetic variation in SNCA and APOE on cerebrospinal fluid protein levels in patients with Parkinson’s disease and controls
- 12:30pm-2:00pm
-
Effect of intra-striatal 6-OHDA lesion on extra-striatal structures in the mouse
Parkinson's disease: Pathophysiology · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Effect of L-DOPA on re-emergent tremor in Parkinson’s disease: A neurophysiological assessment
Tremor · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Effect of marijuana on Essential Tremor: A case report
Tremor · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Effect of vibration on motor performance: A new intervention to improve bradykinesia in Parkinson’s disease?
Parkinson's disease: Pathophysiology · Exhibit Hall located in Hall B, Level 2
- «Previous Page
- 1
- …
- 13
- 14
- 15
- 16
- 17
- …
- 48
- Next Page»